Related Experiment Video

Updated: Jul 5, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

[Statins in coronary patients: a solved issue?]

J Ferrières1

  • 1Service de Cardiologie B, CHU Rangueil, TSA 50032, 31059 Toulouse cedex 9, France. jean.ferrieres@cict.fr

Annales De Cardiologie Et D'Angeiologie
|June 18, 2008
PubMed

Insights

Statin therapy is recommended for coronary artery disease patients, improving long-term outcomes in both acute coronary syndrome and stable angina. Early prescription and adherence to statins are crucial for better clinical results.

Area of Science:

  • Cardiology
  • Pharmacology

Context:

  • Coronary artery disease (CAD) management
  • Evidence from randomized controlled trials (RCTs)
  • Diverse clinical settings including acute coronary syndrome (ACS) and stable angina

Purpose:

  • To evaluate the efficacy of statin prescription in patients with coronary artery disease (CAD)
  • To assess the impact of statin therapy on clinical outcomes in various CAD patient groups

Summary:

  • RCTs consistently demonstrate that statin therapy improves clinical outcomes in CAD patients.
  • Benefits are significant in stable coronary patients with hypercholesterolemia and contribute to favorable long-term prognosis in both acute and stable coronary conditions.
  • While initial benefits in acute coronary syndrome may be less striking, long-term prognosis is positively influenced by statin use.

Impact:

  • Physicians should prioritize prescribing well-tolerated statins promptly for all CAD patients.
  • Long-term patient compliance with statin therapy is essential for sustained cardiovascular benefits.
  • Statin therapy represents a cornerstone in improving the long-term prognosis for individuals with coronary artery disease.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...